MBL2 and susceptibility to pneumonia measurement: Reduced levels of circulating MBL are associated with an increased risk of invasive pneumococcal disease, other bacterial infections (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Clostridium difficile), sepsis, and death from pneumonia (60–62).